do glp 1 reduce cancer risk Could GLP-1 medications help slow progression?⁣ ⁣ A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to The Impact and Safety of

doi: 10.1016/j.jdiacomp.2014.01.012

A huge Danish study looked at 756,636 pregnancies and zoomed in on 529 where women had used GLP 1 drugs like semaglutide or liraglutide in the 8 weeks before or after their last period the earliest stage of pregnancy when organs are forming

In a Phase 2 clinical trial published in The Lancet, the drug significantly improved blood-sugar control and reduced body weight in people with Type 2 diabetes compared with a placebo

J Nucl Cardiol

Glycaemic and non-glycaemic efficacy of once-weekly GLP-1 receptor agonists in people with type 2 diabetes

Regarding hypoglycaemia: as with other incretin-based therapies, the risk of low blood glucose with retatrutide alone is considered low, given its glucose-dependent mechanism of action